<DOC>
	<DOCNO>NCT02023567</DOCNO>
	<brief_summary>Major depressive disorder ( MDD ) one common psychiatric disorder , high recurrence rate , suicide rate disability rate . It 's report global burden cause MDD second rank among disease burden 2020 . China also confront daunt challenge MDD . It 's assess monthly incidence MDD 6.1 % , non-hospitalizing rate reach 92 % non-treatment rate approximate 95 % . However , date , pathogenesis MDD obscure current therapy n't work well . Therefore , 's urgent critical elucidate pathogenesis MDD , develop early diagnostic criterion effective intervention MDD . Considering diversity weight genetic factor environmental factor MDD , project , investigator aim firstly explore effect `` genetic-environmental interaction '' pathogeny MDD classifying MDD `` genetic type '' , `` environmental type '' `` others '' base case-control study . We next conduct neurobiological , neurocognitive psycho-behavioral assessment among MDD , schizophrenia healthy group screen salient endophenotypes establish diagnostic model MDD . The investigator analyse change indicator 8 weeks'medication select potential predictor therapeutic evaluation interventional option MDD patient . Finally , investigator continue 2-year follow-up study test verify predictor prognosis MDD patient .</brief_summary>
	<brief_title>Objective Diagnostic Markers Personalized Intervention MDD Patients</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>1 . For MDD group : Inclusion criterion : Age 1855 , male female ; The diagnosis MDD consistent DSMIV ( M.I.N.I ) Firstepisode relapse ; Certain ability read write complete questionnaire survey psychological assessment . All participant provide write confirmation inform consent prior engage study protocol . Exclusion criterion : Current psychopathology history neurologic condition , include alcohol/substances dependence , diagnosis cognition impairment ; Severe somatic disease , severe cardiocerebral vascular disease , respiratory disease , liver disease , kidney disease , malignant tumor ; Not sign informed consent ; Been engage study . 2 . For Healthy control group Inclusion criterion : age 18 55 year time enrollment ; provide write confirmation inform consent prior engage study . Exclusion criterion : lifetime current diagnosis mental disease ; severe somatic disease , severe cardiocerebral vascular disease , respiratory disease , liver disease , kidney disease , malignant tumor ; sign informed consent ; engage study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>